Search

 
16 results:
11. CHEPLAPHARM acquires Tarceva® from Roche  
The CHEPLAPHARM Group acquires Tarceva® from Roche, thereby expanding its oncology portfolio. Tarceva®, with the active ingredient erlotinib, is used for the treatment of metastatic non-small cell…  
12. Contact  
Location CHEPLAPHARM Switzerland LLC Huebweg 18-20 4102 Binningen, Switzerland Tel.: +41 61 551 21 60 E-mail: info(at)cheplapharm.ch  
13. Basel Area Article on Cheplapharm Switzerland  
Basel Area Article  
14. CHEPLAPHARM acquires Roaccutane® from Roche  
Binningen, January 18, 2024   The CHEPLAPHARM Group acquires the global rights to Roaccutane® from Roche, thereby strengthening its dermatological portfolio. The medicine, which is based on the…  
15. CHEPLAPHARM opens Swiss subsidiary and wins Agnes Wasem as Managing Director  
Binningen / Greifswald   CHEPLAPHARM Arzneimittel GmbH, headquartered in Greifswald/Germany, has established a Swiss national subsidiary in Binningen. Managing Director of the newly founded…  
16. Thank you-page  
Thank you for your message  
Search results 11 until 16 of 16
Back to top expand_less